Walgreens Boots Alliance News

Morgan Stanley Adjusts Price Target on Walgreens Boots Alliance to $16 From $20

MT NewswiresApr 26 11:39 ET

Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV)

TipRanksApr 17 05:10 ET

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH)

TipRanksApr 15 07:20 ET

RBC Capital Cuts Walgreens Boots Alliance's Price Target to $22 From $26, Sector Perform Rating Kept

MT NewswiresApr 12 08:25 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaApr 3 08:23 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaApr 1 09:06 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Walgreens Boots Alliance (WBA) and Kodiak Sciences (KOD)

TipRanksApr 1 03:40 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaMar 26 07:48 ET

Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Elevance Health (ELV) and Stoke Therapeutics (STOK)

TipRanksMar 26 06:30 ET

Walgreens Boots Alliance Sell Rating: Declining Sales and Uncertain Future Direction

TipRanksMar 26 06:26 ET

Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Walgreens Boots Alliance (WBA)

TipRanksMar 21 06:10 ET

Barclays Remains a Sell on Walgreens Boots Alliance (WBA)

TipRanksMar 20 03:16 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaMar 18 11:25 ET

Buy Rating Affirmed for Walgreens Boots Alliance With Positive Outlook on Strategic Review and Market Share Gains

TipRanksMar 14 06:16 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaFeb 26 08:40 ET

Walgreens Boots Alliance Analyst Ratings

BenzingaFeb 20 11:00 ET

HSBC Cuts Walgreens Stock Price Target to $20, Downgrades to Reduce

InvestingFeb 20 10:58 ET

Walgreens Boots Alliance Downgraded to Sell Amidst Structural Challenges and Negative Industry Headwinds

TipRanksFeb 20 10:36 ET

HSBC Downgrades Walgreens Boots Alliance to Reduce From Hold, Adjusts Price Target to $20 From $27

MT NewswiresFeb 20 10:23 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Walgreens Boots Alliance (WBA) and Twist Bioscience (TWST)

TipRanksFeb 7 10:20 ET